Oxalacetic acid
|
Basic information |
| Metabolite name | Oxalacetic acid |
 | HMDB0000223 |
 |
C00036 |
 |
970 |
| Synonyms | Oxalacetate; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | Oxalacetic acid |
| HMDB0000223 |
|
C00036 |
|
970 |
| Synonyms | Oxalacetate; |
| No. of studies | 6 |
|
Relationship between Oxalacetic acid and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M102 | Type1 | severe MDD group vs. control group | Urine | Human | Down |
| Study M550 | Type2 | CUMS + GTD group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M664 | Type2 | CSDS + Dl-3-n-butylphthalide group vs. CSDS group | Hippocampus | C57BL/6 J mouse | Down |
| Study M762 | Type1 | corticosterone group vs. control group | Liver | Wistar rat | Down |
| Study M762 | Type2 | corticosterone + metformin group vs. corticosterone group | Liver | Wistar rat | Up |
| Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M894 | Type1 | electromagnetic field exposure group vs. control group | Serum | C57BL/6J mouse | Down |